WallStreetZenWallStreetZen

NASDAQ: SNOA
Sonoma Pharmaceuticals Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

SNOA past revenue growth

How has SNOA's revenue growth performed historically?
Company
-1.96%
Industry
10.21%
Market
17.33%
SNOA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
SNOA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
SNOA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

SNOA earnings and revenue history

Current Revenue
$12.3M
Current Earnings
-$5.1M
Current Profit Margin
-41.2%

SNOA Return on Equity

Current Company
-73.6%
Current Industry
15.4%
Current Market
188%
SNOA's Return on Equity (-73.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when SNOA announces earnings.

SNOA Return on Assets

Current Company
-33.6%
Current Industry
3.4%
SNOA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

SNOA Return on Capital Employed

Current Company
-44.38%
Current Industry
5.1%
SNOA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

SNOA vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
SNOA$12.31M-$4.95M-$5.08M-7.57%N/A
YCBD$23.45M-$17.13M-$23.98M+150.64%N/A
LSDI$16.73k-$9.75M-$11.30MN/AN/A
PRFX$0.00-$9.57M-$9.34MN/AN/A
SBFM$24.09M-$3.82M-$4.51M+481.16%N/A
View Top Pharmaceutical Stocks

SNOA earnings dates

Next earnings date
Jun 19, 2024

Sonoma Pharmaceuticals Earnings & Revenue FAQ

What were SNOA's earnings last quarter?

On Invalid Date, Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q4 2023 earnings per share (EPS) of -$0.08, up 87.1% year over year. Total Sonoma Pharmaceuticals earnings for the quarter were -$866.00 thousand. In the same quarter last year, Sonoma Pharmaceuticals's earnings per share (EPS) was -$0.62.

If you're new to stock investing, here's how to buy Sonoma Pharmaceuticals stock.

What was SNOA's earnings growth in the past year?

As of Q2 2024, Sonoma Pharmaceuticals's earnings has grown year over year. Sonoma Pharmaceuticals's earnings in the past year totalled -$5.08 million.

What is SNOA's earnings date?

Sonoma Pharmaceuticals's earnings date is Invalid Date. Add SNOA to your watchlist to be reminded of SNOA's next earnings announcement.

What was SNOA's revenue last quarter?

On Invalid Date, Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q4 2023 revenue of $3.14 million up 6.59% year over year. In the same quarter last year, Sonoma Pharmaceuticals's revenue was $2.94 million.

What was SNOA's revenue growth in the past year?

As of Q2 2024, Sonoma Pharmaceuticals's revenue has grown -1.96% year over year. This is 12.17 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.21%. Sonoma Pharmaceuticals's revenue in the past year totalled $12.31 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.